Pfizer began its COVID-19 booster shot trial today.
Results are expected in 6 months.
Pfizer began its COVID-19 booster shot trial today.
Results are expected in 6 months.
Researchers from the Oxford Vaccine Group's Com-COV vaccine trial discovered that adults were more likely to suffer from mild to..